相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Multicenter Alzheimer's and Parkinson's disease immune biomarker verification study
Frederic Brosseron et al.
ALZHEIMERS & DEMENTIA (2020)
The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer's disease
Alessandra Webers et al.
IMMUNOLOGY AND CELL BIOLOGY (2020)
MIF and insulin: Lifetime companions from common genesis to common pathogenesis
Stanislava Stosic-Grujicic et al.
CYTOKINE (2020)
Pathogenic contribution of the Macrophage migration inhibitory factor family to major depressive disorder and emerging tailored therapeutic approaches
Maria Cristina Petralia et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Macrophage Migration Inhibitory Factor Regulates U1 Small Nuclear RNP Immune Complex-Mediated Activation of the NLRP3 Inflammasome
Min Sun Shin et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Lopinavir-NO, a nitric oxide-releasing HIV protease inhibitor, suppresses the growth of melanoma cells in vitro and in vivo
Svetlana Paskas et al.
INVESTIGATIONAL NEW DRUGS (2019)
MIF family proteins in genitourinary cancer: tumorigenic roles and therapeutic potential
Justin C. Penticuff et al.
NATURE REVIEWS UROLOGY (2019)
Evolving complexity of MIF signaling
Stanislovas S. Jankauskas et al.
CELLULAR SIGNALLING (2019)
Senescence as a main mechanism of Ritonavir and Ritonavir-NO action against melanoma
Svetlana Paskas et al.
MOLECULAR CARCINOGENESIS (2019)
Connecting Metainflammation and Neuroinflammation Through the PTN-MK-RPTPβ/ζ Axis: Relevance in Therapeutic Development
Gonzalo Herradon et al.
FRONTIERS IN PHARMACOLOGY (2019)
Role of Macrophage Migration Inhibitory Factor (MIF) in Melanoma
Laura Soumoy et al.
CANCERS (2019)
Attenuation of Macrophage Migration Inhibitory Factor-Stimulated Signaling via S-Nitrosylation
Kengo Nakahara et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2019)
Protective effect of ISO-1 against advanced glycation end product aggravation of PC12 cell injury induced by Aβ1-40
Ming Yu et al.
MOLECULAR MEDICINE REPORTS (2019)
Macrophage Migration Inhibitory Factor Mediates Neuroprotective Effects by Regulating Inflammation, Apoptosis and Autophagy in Parkinson's Disease
Siying Li et al.
NEUROSCIENCE (2019)
AAV2/9-mediated overexpression of MIF inhibits SOD1 misfolding, delays disease onset, and extends survival in mouse models of ALS
Marcel F. Leyton-Jaimes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Upregulation of MIF as a defense mechanism and a biomarker of Alzheimer's disease
Si Zhang et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
Macrophage migration inhibitory Factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus
Joshua B. Bilsborrow et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2019)
Upregulated Expression of Macrophage Migration Inhibitory Factor, Its Analogue D-Dopachrome Tautomerase, and the CD44 Receptor in Peripheral CD4 T Cells from Clinically Isolated Syndrome Patients with Rapid Conversion to Clinical Defined Multiple Sclerosis
Eugenio Cavalli et al.
MEDICINA-LITHUANIA (2019)
Transcriptomic Analysis Reveals Involvement of the Macrophage Migration Inhibitory Factor Gene Network in Duchenne Muscular Dystrophy
Salvo Danilo Lombardo et al.
GENES (2019)
Overexpression of Macrophage Migration Inhibitory Factor and Its Homologue D-Dopachrome Tautomerase as Negative Prognostic Factor in Neuroblastoma
Eugenio Cavalli et al.
BRAIN SCIENCES (2019)
Understanding and predicting the longitudinal course of dementia
Rene J. F. Melis et al.
CURRENT OPINION IN PSYCHIATRY (2019)
Role of MIF and D-DT in immune-inflammatory, autoimmune, and chronic respiratory diseases: from pathogenic factors to therapeutic targets
Sven Gunther et al.
DRUG DISCOVERY TODAY (2019)
Amelioration of Alzheimer's disease pathology and cognitive deficits by immunomodulatory agents in animal models of Alzheimer's disease
Bridget Martinez et al.
NEURAL REGENERATION RESEARCH (2019)
Alzheimer's disease
C. A. Lane et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Suppression of MIF-induced neuronal apoptosis may underlie the therapeutic effects of effective components of Fufang Danshen in the treatment of Alzheimer's disease
Cheng-jie Liang et al.
ACTA PHARMACOLOGICA SINICA (2018)
Emerging immune targets for the treatment of multiple myeloma
Atif Sohail et al.
IMMUNOTHERAPY (2018)
Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: In silico and in vivo evidences
Paolo Fagone et al.
JOURNAL OF NEUROIMMUNOLOGY (2018)
Tau-targeting therapies for Alzheimer disease
Erin E. Congdon et al.
NATURE REVIEWS NEUROLOGY (2018)
MIF inhibits the formation and toxicity of misfolded SOD1 amyloid aggregates: implications for familial ALS
Neta Shvil et al.
CELL DEATH & DISEASE (2018)
Overexpression of macrophage migration inhibitory factor and functionally-related genes, D-DT, CD74, CD44, CXCR2 and CXCR4, in glioblastoma
Mario Presti et al.
ONCOLOGY LETTERS (2018)
Macrophage migration inhibitory factor is required for NLRP3 inflammasome activation
Tali Lang et al.
NATURE COMMUNICATIONS (2018)
Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach
Katia Mangano et al.
Oncotarget (2018)
A review of clinical treatment considerations of donepezil in severe Alzheimer's disease
Aida Adlimoghaddam et al.
CNS NEUROSCIENCE & THERAPEUTICS (2018)
Anticancer and Differentiation Properties of the Nitric Oxide Derivative of Lopinavir in Human Glioblastoma Cells
Maria Sofia Basile et al.
MOLECULES (2018)
Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis
R. J. Fox et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Innate immune activation in Alzheimer's disease
Ming-Ming Wang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2018)
MIF family cytokines in cardiovascular diseases and prospects for precision-based therapeutics
Pathricia V. Tilstam et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2017)
Role of macrophage migration inhibitory factor in head and neck cancer and novel therapeutic targets: A systematic review
Jerome R. Lechien et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2017)
Therapeutic strategies to address neuronal nitric oxide synthase deficiency and the loss of nitric oxide bioavailability in Duchenne Muscular Dystrophy
Cara A. Timpani et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
MIF and D-DT are potential disease severity modifiers in male MS subjects
Gil Benedek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Role of neuroinflammation in neurodegeneration: new insights
Roisin M. McManus et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Macrophage Migration Inhibitory Factor is subjected to glucose modification and oxidation in Alzheimer's Disease
Omar Kassaar et al.
SCIENTIFIC REPORTS (2017)
'Type 3' diabetes: a brain insulin-resistant state linked to Alzheimer's disease
Ken Shaw
PRACTICAL DIABETES (2017)
Markers of neuroinflammation associated with Alzheimer′s disease pathology in older adults
Julius Popp et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease
Myles R. Minter et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
Bruno Dubois et al.
ALZHEIMERS & DEMENTIA (2016)
Drug treatments in Alzheimer's disease
Robert Briggs et al.
CLINICAL MEDICINE (2016)
Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
Jose Joaquin Merino et al.
CURRENT ALZHEIMER RESEARCH (2016)
Targeting MIF in Cancer: Therapeutic Strategies, Current Developments, and Future Opportunities
Ciaran O'Reilly et al.
MEDICINAL RESEARCH REVIEWS (2016)
Endogenous macrophage migration inhibitory factor reduces the accumulation and toxicity of misfolded SOD1 in a mouse model of ALS
Marcel F. Leyton-Jaimes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Inflammatory Cytokines and Alzheimer's Disease: A Review from the Perspective of Genetic Polymorphisms
Fan Su et al.
NEUROSCIENCE BULLETIN (2016)
Oxidized macrophage migration inhibitory factor is a potential new tissue marker and drug target in cancer
Alexander Schinagl et al.
ONCOTARGET (2016)
Effects of NO-Hybridization on the Immunomodulatory Properties of the HIV Protease Inhibitors Lopinavir and Ritonavir
Paolo Fagone et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2015)
Selective Targeting of a Disease-Related Conformational Isoform of Macrophage Migration Inhibitory Factor Ameliorates Inflammatory Conditions
Michael Thiele et al.
JOURNAL OF IMMUNOLOGY (2015)
Deficiency of macrophage migration inhibitory factor attenuates tau hyperphosphorylation in mouse models of Alzheimer's disease
Shu-Qin Li et al.
JOURNAL OF NEUROINFLAMMATION (2015)
Neuroinflammation in Alzheimer's disease
Michael T. Heneka et al.
LANCET NEUROLOGY (2015)
The NO-modified HIV protease inhibitor as a valuable drug for hematological malignancies: Role of p70S6K
Danijela Maksimovic-Ivanic et al.
LEUKEMIA RESEARCH (2015)
Macrophage Migration Inhibitory Factor as a Chaperone Inhibiting Accumulation of Misfolded SOD1
Adrian Israelson et al.
NEURON (2015)
Down-regulation of MIF by NFκB under hypoxia accelerated neuronal loss during stroke
Si Zhang et al.
FASEB JOURNAL (2014)
Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014
L. S. Schneider et al.
JOURNAL OF INTERNAL MEDICINE (2014)
Effect of Proinflammatory Gene Polymorphisms on the Risk of Alzheimer's Disease
Andrea Flex et al.
NEURODEGENERATIVE DISEASES (2014)
D-dopachrome tautomerase (D-DT or MIF-2): Doubling the MIF cytokine family
Melanie Merk et al.
CYTOKINE (2012)
Neutralization of Macrophage Migration Inhibitory Factor (MIF) by Fully Human Antibodies Correlates with Their Specificity for the β-Sheet Structure of MIF
Randolf J. Kerschbaumer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease-like pathology and cognitive decline
Johannes vom Berg et al.
NATURE MEDICINE (2012)
Treatment with a Nitric Oxide-Donating NSAID Alleviates Functional Muscle Ischemia in the Mouse Model of Duchenne Muscular Dystrophy
Gail D. Thomas et al.
PLOS ONE (2012)
Cortical Neurons Develop Insulin Resistance and Blunted Akt Signaling: A Potential Mechanism Contributing to Enhanced Ischemic Injury in Diabetes
Bhumsoo Kim et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
How to Get from Here to There: Macrophage Recruitment in Alzheimer's Disease
K. Rezai-Zadeh et al.
CURRENT ALZHEIMER RESEARCH (2011)
Parkinson's disease is associated with increased serum levels of macrophage migration inhibitory factor
Alessandra Nicoletti et al.
CYTOKINE (2011)
The Role of Macrophage Migration Inhibitory Factor in Alzheimer's Disease
Michael Bacher et al.
MOLECULAR MEDICINE (2010)
Cardiac macrophage migration inhibitory factor inhibits JNK pathway activation and injury during ischemia/reperfusion
Dake Qi et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer's disease
Julius Popp et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2009)
Bioplex analysis of plasma cytokines in Alzheimer's disease and mild cognitive impairment
Kang Soo Lee et al.
IMMUNOLOGY LETTERS (2008)
Lack of macrophage migration inhibitory factor protects mice against concanavalin A-induced liver injury
H Nakajima et al.
LIVER INTERNATIONAL (2006)
Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease
Nikunj S. Patel et al.
JOURNAL OF NEUROINFLAMMATION (2005)
Polymorphisms of the macrophage inhibitory factor and C-reactive protein genes in subjects with Alzheimer's dementia
A Flex et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2004)
Regulation of macrophage migration inhibitory factor expression by glucocorticoids in vivo
G Fingerle-Rowson et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Induction of cytokines in glial cells surrounding cortical β-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology
G Mehlhorn et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2000)
Glutamine synthetase, hemoglobin α-chain, and macrophage migration inhibitory factor binding to amyloid β-protein:: their identification in rat brain by a novel affinity chromatography and in Alzheimer's disease brain by immunoprecipitation
R Oyama et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY (2000)
分享论文
